{"meshTagsMajor":["Chromosome Inversion"],"meshTags":["Adolescent","Adult","Aged","Aged, 80 and over","Chromosome Inversion","Chromosomes, Human, Pair 3","Core Binding Factor Alpha 2 Subunit","Female","Genes, ras","Humans","Leukemia, Myeloid, Acute","Male","Middle Aged","Myelodysplastic Syndromes","Neurofibromin 1","Prognosis","Proto-Oncogene Proteins","Proto-Oncogene Proteins p21(ras)","Survival Rate","Translocation, Genetic","Young Adult","ras Proteins"],"meshMinor":["Adolescent","Adult","Aged","Aged, 80 and over","Chromosomes, Human, Pair 3","Core Binding Factor Alpha 2 Subunit","Female","Genes, ras","Humans","Leukemia, Myeloid, Acute","Male","Middle Aged","Myelodysplastic Syndromes","Neurofibromin 1","Prognosis","Proto-Oncogene Proteins","Proto-Oncogene Proteins p21(ras)","Survival Rate","Translocation, Genetic","Young Adult","ras Proteins"],"genes":["RUNX1","KRAS","NRAS","NF1 genes"],"publicationTypes":["Letter"],"title":"The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML.","pubmedId":"21283084"}